Jane Street Group, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $5.11 Million - $6.95 Million	74,100 New	74,100 $5.21 Million
Q1 2022 May 17, 2022	SELL	$74.28 - $92.69 $757,656 - $945,438	-10,200 Reduced 6.51%	146,400 $11.3 Million
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $5.96 Million - $7.6 Million	83,100 Added 113.06%	156,600 $13.8 Million
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $2.18 Million - $2.49 Million	-29,100 Reduced 28.36%	73,500 $5.68 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $2.76 Million - $3.09 Million	-36,500 Reduced 26.24%	102,600 $8.56 Million
Q1 2021 May 18, 2021	SELL	$74.73 - $90.69 $8.44 Million - $10.2 Million	-113,000 Reduced 44.82%	139,100 $10.5 Million
Q4 2020 Feb 17, 2021	BUY	$72.61 - $90.2 $2 Million - $2.48 Million	27,500 Added 12.24%	252,100 $22.1 Million
Q3 2020 Nov 17, 2020	BUY	$71.87 - $131.03 $1.29 Million - $2.35 Million	17,900 Added 8.66%	224,600 $17.1 Million
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $12.5 Million - $19.5 Million	157,100 Added 316.73%	206,700 $25.5 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $3.85 Million - $5.22 Million	-53,900 Reduced 52.08%	49,600 $4.19 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $6.26 Million - $8.41 Million	97,400 Added 1596.72%	103,500 $8.75 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $3.12 Million - $3.94 Million	-46,300 Reduced 88.36%	6,100 $411,000
Q2 2019 Aug 15, 2019	BUY	$80.35 - $93.9 $3.43 Million - $4.01 Million	42,700 Added 440.21%	52,400 $4.49 Million
Q1 2019 May 16, 2019	SELL	$84.2 - $98.62 $1.09 Million - $1.28 Million	-13,000 Reduced 57.27%	9,700 $862,000
Q4 2018 Feb 15, 2019	BUY	$80.14 - $106.07 $568,994 - $753,097	7,100 Added 45.51%	22,700 $1.93 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $695,008 - $782,328	-7,400 Reduced 32.17%	15,600 $1.51 Million
Q2 2018 Aug 15, 2018	BUY	$76.01 - $99.03 $722,095 - $940,785	9,500 Added 70.37%	23,000 $2.17 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $2.34 Million - $2.79 Million	-30,100 Reduced 69.04%	13,500 $1.09 Million
Q4 2017 Feb 15, 2018	BUY	$80.76 - $95.13 $3.34 Million - $3.93 Million	41,300 Added 1795.65%	43,600 $3.89 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $185,380 - $218,385	2,300	2,300 $214,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account